These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10593662)

  • 1. The human renin infused rat: use as an in vivo model for the biological evaluation of human renin inhibitors.
    Bolger G; Vigeant JC; Liard F; Simoneau B; Thibeault D; Pilote L; Lamarre D; Jung G; Anderson P; Jaramillo J
    Can J Physiol Pharmacol; 1999 Nov; 77(11):886-95. PubMed ID: 10593662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vivo effects of irbesartan and losartan on angiotensin II receptor binding in the rat kidney following oral administration.
    Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
    Clin Sci (Lond); 2000 Oct; 99(4):331-41. PubMed ID: 10995600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
    Ryan MJ; Hicks GW; Batley BL; Rapundalo ST; Patt WC; Taylor DG; Keiser JA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of renin-angiotensin system in hypertensive effect of cadmium in rats.
    Lall SB; Peshin SS; Gulati K; Khattar S; Das N; Seth SD
    Indian J Exp Biol; 1997 Apr; 35(4):338-91. PubMed ID: 9315231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin.
    Montenegro MF; Pessa LR; Tanus-Santos JE
    Eur J Pharmacol; 2009 Apr; 607(1-3):173-7. PubMed ID: 19233159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
    Muneta S
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiotensin-converting enzyme in human hand veins.
    Chalon S; Bedarida GV; Moreno H; Tejura B; Urae A; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Jan; 65(1):58-65. PubMed ID: 9951431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II supports sympathetically mediated vasopressor response to footshock-stress.
    Israel A; Sosa-Canache B
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S84-8. PubMed ID: 11986902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.
    Wood JM; Criscione L; de Gasparo M; Bühlmayer P; Rüeger H; Stanton JL; Jupp RA; Kay J
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):221-6. PubMed ID: 2476594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314).
    Miyazaki M; Etoh Y; Iizuka K; Toda N
    J Hypertens Suppl; 1989 Apr; 7(2):S25-7. PubMed ID: 2666609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central choline suppresses plasma renin response to graded haemorrhage in rats.
    Isbil-Buyukcoskun N; Ilcol YO; Cansev M; Hamurtekin E; Ozluk K; Ulus IH
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1023-31. PubMed ID: 18518880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.